Tasha Armour founder and CEO of Rare Ovarian Cancer Incorporated – ROC Inc. talks to three leading international experts on Granulosa Cell Tumours GCT.
Dr Simon Chu research head of Hormone Cancer Therapeutic Laboratory at the Hudson Institute of Medical Research.
Professor Peter Fuller AM is physician-scientist who leads the Centre for Endocrinology and Metabolism at the Hudson Institute of Medical Research. Head of Endocrinology Unit, Monash Health
Professor Tom Jobling OAM, Director of Gynaecology Oncology at Monash Health
Granulosa Cell Tumour GCT has two subtypes adult aGCT and juvenile jGCT this is an opportunity to hear about what the latest developments for both of these subtypes and what is the future direction is for research and treatment for all GCT.
Sunday 1st March 8:00am AEDT
Or visit the webinar landing page below
Granulosa Cell Tumour GCT, a rare ovarian cancer Q&A on Treatment, Challenges and Research
Webinar is hosted on Bigmarker.com
Troubleshooting for attendees – BigMarker
If you have any issues or questions about the webinar email us at